Immune Thrombocytopenia Clinical Trials in Boston, Massachusetts
2 recruitingBoston, Massachusetts
Showing 1–2 of 2 trials
Recruiting
Phase 2
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
Immune Thrombocytopenia
Incyte Corporation56 enrolled40 locationsNCT07104565
Recruiting
Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia
Immune Thrombocytopenia
Massachusetts General Hospital100 enrolled1 locationNCT06817395